146 studies found for:    "Rothmund-Thomson Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Rothmund-Thomson Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Calcium Absorption in Patients With Rothmund-Thomson Syndrome
Condition: Rothmund-Thomson Syndrome
Intervention:
2 Terminated Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Condition: Idiopathic Interstitial Pneumonias
Intervention:
3 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
4 Recruiting A Linkage and Association Study in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
5 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
6 Unknown  Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
Conditions: Emphysema;   Alveolitis, Fibrosing;   Cystic Fibrosis;   Bronchiectasis;   Lung Diseases
Intervention: Procedure: Pulmonary rehabilitation programme
7 Completed
Has Results
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
Conditions: Alveolitis, Fibrosing;   Fibrosis, Pulmonary;   Hypertension, Pulmonary
Intervention: Drug: sildenafil
8 Recruiting Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: BMS-986020;   Drug: Placebo matching with BMS-986020
9 Recruiting Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
10 Unknown  Study of Default Options in Advance Directives
Conditions: COPD;   Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy;   Idiopathic Pulmonary Fibrosis;   Other Interstitial Lung Disease Without Curative Therapy;   Congestive Heart Failure;   NYHA Class IV or NYHA Class III Plus 1 Hospitalization in the Past Year;   Malignancy;   Any Stage 3B or 4 Solid Tumor
Interventions: Other: Comfort Default AD forms;   Other: Life Extension Default AD forms;   Other: Standard Default AD forms
11 Recruiting Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
12 Unknown  Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Placebo;   Drug: AZAPRED
13 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
14 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate
15 Recruiting Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
16 Recruiting The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Interstitial Pneumonitis;   Desquamative Interstitial Pneumonia
Intervention: Other: Aerobic Exercise Training
17 Active, not recruiting A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention: Drug: aerosol interferon-gamma
18 Completed Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Tetrathiomolybdate
19 Recruiting Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Diffuse Parenchymal Lung Disease;   Interstitial Lung Disease
Interventions: Drug: sirolimus;   Other: Placebo
20 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years